Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review.
van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, Bus SA; International Working Group on the Diabetic Foot.
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:84-98. doi: 10.1002/dmrr.2701.
PMID:26340966
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.
Xiong J, Hu H, Guo R, Wang H, Jiang H.
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
PMID:33995278
[Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].
Shen JF, Jiang RM, Wang ZQ, Li M, Li J, Xie SY, Kang JJ.
Zhonghua Shao Shang Za Zhi. 2020 Oct 20;36(10):947-952. doi: 10.3760/cma.j.cn501120-20190726-00315.
PMID:33105947
Development and validation of a risk prediction model for the recurrence of foot ulcer in type 2 diabetes in China: A longitudinal cohort study based on a systematic review and meta-analysis.
Wang M, Chen D, Fu H, Xu H, Lin S, Ge T, Ren Q, Song Z, Ding M, Chang J, Fan T, Xing Q, Sun M, Li X, Chen L, Chang B.
Diabetes Metab Res Rev. 2023 May;39(4):e3616. doi: 10.1002/dmrr.3616. Epub 2023 Feb 4.
PMID:36657181
Guidelines on the classification of diabetic foot ulcers (IWGDF 2019).
Monteiro-Soares M, Russell D, Boyko EJ, Jeffcoate W, Mills JL, Morbach S, Game F; International Working Group on the Diabetic Foot (IWGDF).
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3273. doi: 10.1002/dmrr.3273.